.png)
How to Make Your Mitochondria Fight Lyme Borreliosis by Surfing Oxygen Waves
RESOURCES
Defining the Biggest and Most
Complex Industry in Human History
Data Science for Accelerating Aging Research and R&D, The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision-Making and De-Risking
Deep Breath: A Systemic Approach to Immune Health and Longevity
About the Authors
Arkadi Prokopov is a physician specialising in integrative and mitochondrial medicine, with more than three decades of experience in intermittent hypoxic-hyperoxic training. His work combines clinical medicine, biomedical research and personalised performance optimisation, including more than 15 years of experience supporting elite athletes in Europe and the United States.
Dr Prokopov developed MITOPRO — Mitochondria Optimization Protocol, a highly individualised approach to hypoxic training designed around each person’s health status, physiological response and performance objectives. He is the author of numerous scientific and popular publications on biomedicine, biogerontology and the application of interval hypoxic training in health and sport, and holds two patents related to this field.
Since 1994, Dr Prokopov has practised medicine internationally, working in Germany and later in the United States as an IHHT expert. Since 2008, he has conducted clinical research, consultations and professional education in integrative and mitochondrial medicine from Mallorca, Spain. He also trains physicians and practitioners in his proprietary hypoxic-training methodology through specialised seminars and educational programmes.
Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.
Mr. Kaminskiy is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.
-
He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment and exit strategies.
-
He is a frequent speaker on the topics of AI and Longevity, including conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities.
Mr. Kaminskiy serves as managing trustee of Biogerontology Research Foundation, the UK’s oldest Longevity focused charity.
